This
page
is
part
of
the
FHIR
Specification
(v3.0.2:
STU
3).
(v3.5.0:
R4
Ballot
#2).
The
current
version
which
supercedes
this
version
is
5.0.0
.
For
a
full
list
of
available
versions,
see
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
Work
Group
|
Maturity Level : 1 |
|
Use Context : Any |
This is a value set defined by the FHIR project.
Summary
| Defining URL: | http://hl7.org/fhir/ValueSet/adverse-event-causality-assess |
| Version: | 3.5.0 |
| Name: | AdverseEventCausalityAssessment |
| Title: | AdverseEventCausalityAssessment |
| Definition: |
TODO. |
| Committee: |
Work
Group
|
| OID: |
|
| Source Resource | XML / JSON |
This value set is used in the following places:
This value set includes codes from the following code systems:
This
expansion
generated
19
Apr
2017
Aug
2018
This
value
set
contains
2
6
concepts
Expansion
based
on
http://hl7.org/fhir/adverse-event-causality-assess
http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess
version
3.0.2
3.5.0
All
codes
from
system
http://hl7.org/fhir/adverse-event-causality-assess
http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess
| Code | Display | Definition |
| Certain | Certain | i) Event or laboratory test abnormality, with plausible time relationship to drug intake ii) Cannot be explained by disease or other drugs iii) Response to withdrawal plausible (pharmacologically, pathologically) iv) Event definitive pharmacologically or phenomenologically (i.e. an objective and specific medical disorder or a recognized pharmacological phenomenon) v) Re-challenge satisfactory, if necessary. |
|
|
|
i) Event or laboratory test abnormality, with reasonable time relationship to drug intake ii) Unlikely to be attributed to disease or other drugs iii) Response to withdrawal clinically reasonable iv) Re-challenge not required. |
| Possible | Possible | i) Event or laboratory test abnormality, with reasonable time relationship to drug intake ii) Could also be explained by disease or other drugs iii) Information on drug withdrawal may be lacking or unclear. |
|
|
|
i) Event or laboratory test abnormality, with a time to drug intake that makes a relationship improbable (but not impossible) ii) Disease or other drugs provide plausible explanations. |
| Conditional-Classified | Conditional/Classified | i) Event or laboratory test abnormality ii) More data for proper assessment needed, or iii) Additional data under examination. |
| Unassessable-Unclassifiable | Unassessable/Unclassifiable | i) Report suggesting an adverse reaction ii) Cannot be judged because information is insufficient or contradictory iii) Data cannot be supplemented or verified. |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
|
|
A
few
code
lists
that
FHIR
defines
are
hierarchical
-
each
code
is
assigned
a
level.
|
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
| Display | The display (used in the display element of a Coding ). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |